Axcelis ( (ACLS) ) has released its Q2 earnings. Here is a breakdown of the information Axcelis presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Axcelis Technologies, Inc., based in Beverly, Massachusetts, is a prominent player in the semiconductor industry, specializing in the design and manufacture of ion implantation systems, a critical component in integrated circuit manufacturing.
In the second quarter of 2025, Axcelis reported robust financial results despite facing a cyclical downturn in several markets. The company achieved a revenue of $194.5 million, with a GAAP gross margin of 44.9% and a non-GAAP gross margin of 45.2%.
Key financial highlights include a GAAP operating margin of 14.9% and a non-GAAP operating margin of 17.7%. The company also reported a GAAP diluted earnings per share of $0.98 and a non-GAAP diluted earnings per share of $1.13. Axcelis increased its share repurchase activity to $45 million, demonstrating confidence in its long-term business fundamentals.
Looking ahead, Axcelis management remains focused on innovation and customer collaboration to drive long-term growth and profitability. The company expects third-quarter revenues of approximately $200 million, with GAAP earnings per diluted share projected at $0.87 and non-GAAP earnings per share at $1.00.